Mycenax Biotech
About:
Mycenax Biotech is a biologics CDMO company developing recombinant proteins, enzymes, antibodies, antibody-drug conjugates.
Website: https://www.mycenax.com.tw
Top Investors: JCR Pharmaceuticals
Description:
Mycenax Biotech provides biopharmaceutical services and solutions for drug development and production. Mycenax has moved its focus to developing technological platforms, creating and growing GMP operations, meeting a variety of customer needs, and offering simplified and customized CDMO services.
Total Funding Amount:
$56M
Headquarters Location:
Zhuan, Zhejiang, China
Founded Date:
2001-01-01
Contact Email:
Info(AT)mycenax.com.tw
Founders:
Number of Employees:
251-500
Last Funding Date:
2022-07-27
IPO Status:
Public
Industries:
© 2025 bioDAO.ai